| Kaberi K Mozumder, NP | |
|
120 Makani Rd, Makawao, HI 96768 | |
| (808) 268-2025 | |
| Not Available |
| Full Name | Kaberi K Mozumder |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 120 Makani Rd, Makawao, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609107655 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0200X | Nurse Practitioner - Pediatrics | NP18767 (California) | Secondary |
| 363LP0200X | Nurse Practitioner - Pediatrics | APRN2724 (Hawaii) | Primary |
| Entity Name | University Clinical Education & Research Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013966845 PECOS PAC ID: 1658275847 Enrollment ID: O20031120000276 |
News Archive
Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health.
Cases of drug-resistant tuberculosis are forecasted to increase in the four high burden countries (India, the Philippines, Russia, and South Africa) between 2000 and 2040, with the upturn likely to be a result of increased transmission of drug-resistant tuberculosis between people, rather than by strains acquiring resistance to anti-tuberculosis drugs, according to a study published in The Lancet Infectious Diseases.
The woman's condition, known as prosopamnesia, is extremely rare and has only been found in a handful of people around the world, according to University of Queensland cognitive neuroscientist Professor Jason Mattingley.
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are well-recognized causes of progressive liver disease leading to cirrhosis and hepatocellular carcinoma.
A small compound called an aptamer that specifically targets and stimulates a human immune cell can greatly increase the effectiveness of an immunotherapeutic drug designed to destroy malignant or virus-infected cells. The development of a novel apatamer that recognizes activated T-lymphocytes and can boost the therapeutic effect of cell-based vaccines is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaberi K Mozumder, NP 677 Ala Moana Blvd Ste 1001, Honolulu, HI 96813-5408 Ph: (808) 469-4920 | Kaberi K Mozumder, NP 120 Makani Rd, Makawao, HI 96768 Ph: (808) 268-2025 |
News Archive
Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health.
Cases of drug-resistant tuberculosis are forecasted to increase in the four high burden countries (India, the Philippines, Russia, and South Africa) between 2000 and 2040, with the upturn likely to be a result of increased transmission of drug-resistant tuberculosis between people, rather than by strains acquiring resistance to anti-tuberculosis drugs, according to a study published in The Lancet Infectious Diseases.
The woman's condition, known as prosopamnesia, is extremely rare and has only been found in a handful of people around the world, according to University of Queensland cognitive neuroscientist Professor Jason Mattingley.
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are well-recognized causes of progressive liver disease leading to cirrhosis and hepatocellular carcinoma.
A small compound called an aptamer that specifically targets and stimulates a human immune cell can greatly increase the effectiveness of an immunotherapeutic drug designed to destroy malignant or virus-infected cells. The development of a novel apatamer that recognizes activated T-lymphocytes and can boost the therapeutic effect of cell-based vaccines is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
› Verified 4 days ago
Rina Kojima Rousek, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 Pukalani St, Makawao, HI 96768 Phone: 808-242-6464 Fax: 808-984-7445 | |
Liat Miller, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 81 Makawao Ave Ste 100, Makawao, HI 96768 Phone: 808-573-8900 Fax: 808-573-7505 | |
Dan Baston, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 81 Makawao Ave Ste 25, Makawao, HI 96768 Phone: 808-573-8900 Fax: 808-572-3027 | |
Ms. Cristina Elizabeth Prokop, A.P.R.N. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 81 Makawao Ave Ste 100, Makawao, HI 96768 Phone: 808-573-8900 Fax: 808-572-3027 | |
Robin Lisa Garrison, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 222 Aliiolani St, Makawao, HI 96768 Phone: 808-463-2210 | |
Mrs. Bronwen Stephanie Peternell, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1135 Makawao Ave Ste 202, Makawao, HI 96768 Phone: 808-495-7681 Fax: 949-655-5945 |